Blood Cancer Journal - Table of Contents alert Volume 2 May 2012

TABLE OF CONTENTS Volume 2, May 2012 In this issue Original Articles Letter to the Editor Sign up for e-alerts Web feed Advertisement Blood Cancer Journal now indexed by Thomson Reuters ISI We are pleased to inform you that Blood Cancer Journal has been selected for coverage in Thomson Reuter’s products and services and will be indexed and abstracted in: - Science Citation Index Expanded (also known as SciSearch®) - Journal Citation Reports/Science Edition - Current Contents®/Clinical Medicine - Biological Abstracts - BIOSIS Previews   Original Articles Top Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy A H Nwabo Kamdje, G Bassi, L Pacelli, G Malpeli, E Amati, I Nichele, G Pizzolo and M Krampera Blood Cancer J 2012 2: e73; 10.1038/bcj.2012.17 Abstract | Full Text Expression of p89c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells G Manzotti, S A Mariani, F Corradini, R Bussolari, V Cesi, J Vergalli, G Ferrari-Amorotti, V Fragliasso, A R Soliera, S Cattelani, G Raschellà, T L Holyoake and B Calabretta Blood Cancer J 2012 2: e71; 10.1038/bcj.2012.16 Abstract | Full Text Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL S Mizuta, K Matsuo, T Maeda, T Yujiri, Y Hatta, Y Kimura, Y Ueda, H Kanamori, N Usui, H Akiyama, S Takada, A Yokota, Y Takatsuka, S Tamaki, K Imai, Y Moriuchi, Y Miyazaki, S Ohtake, K Ohnishi and T Naoe Blood Cancer J 2012 2: e72; 10.1038/bcj.2012.18 Abstract | Full Text The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML V Novotny-Diermayr, S Hart, K C Goh, A Cheong, L-C Ong, H Hentze, M K Pasha, R Jayaraman, K Ethirajulu and J M Wood Blood Cancer J 2012 2: e69; 10.1038/bcj.2012.14 Abstract | Full Text Letter to the Editor Top Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN? E Kouroupi, J-J Kiladjian, C Dosquet, M-L Menot, N Bonnin, L Ades, W Vainchenker, C Chomienne and B Cassinat Blood Cancer J 2012 2: e70; 10.1038/bcj.2012.15 Full Text Advertisement Why choose Blood Cancer Journal for your research? - Open access - High visibility - Fast publication - High traffic site For the full Guide to Authors click here   You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.